Pacer Advisors, Inc. Vanda Pharmaceuticals Inc. Transaction History

Pacer Advisors, Inc.

$41.8 Billion
Q3 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 06, 2023	BUY	$6.87 - $10.96 $563,793 - $899,443	82,066 Added 35.48%	313,362 $2.32 Million
Q3 2022 Oct 18, 2022	SELL	$9.44 - $11.76 $231,072 - $287,861	-24,478 Reduced 9.57%	231,296 $2.29 Million
Q2 2022 Aug 12, 2022	BUY	$9.31 - $11.84 $390,898 - $497,126	41,987 Added 19.64%	255,774 $2.79 Million
Q1 2022 Apr 05, 2022	BUY	$10.84 - $16.55 $1.17 Million - $1.78 Million	107,664 Added 101.45%	213,787 $2.42 Million
Q4 2021 Feb 03, 2022	BUY	$15.69 - $21.14 $557,167 - $750,702	35,511 Added 50.29%	106,123 $1.67 Million
Q3 2021 Oct 15, 2021	BUY	$15.35 - $21.27 $209,941 - $290,909	13,677 Added 24.02%	70,612 $1.21 Million
Q2 2021 Jul 21, 2021	BUY	$15.71 - $21.51 $374,086 - $512,196	23,812 Added 71.89%	56,935 $1.23 Million
Q1 2021 Apr 05, 2021	BUY	$13.42 - $20.28 $285,027 - $430,726	21,239 Added 178.72%	33,123 $498,000
Q4 2020 Jan 20, 2021	BUY	$9.77 - $13.81 $10,424 - $14,735	1,067 Added 9.86%	11,884 $156,000
Q3 2020 Oct 19, 2020	BUY	$9.32 - $12.02 $52,574 - $67,804	5,641 Added 108.98%	10,817 $104,000
Q2 2020 Jul 29, 2020	SELL	$9.66 - $12.02 $579 - $721	-60 Reduced 1.15%	5,176 $59,000
Q1 2020 Apr 23, 2020	SELL	$7.5 - $16.8 $40,950 - $91,728	-5,460 Reduced 51.05%	5,236 $60,000
Q4 2019 Feb 10, 2020	SELL	$12.38 - $17.47 $67,211 - $94,844	-5,429 Reduced 33.67%	10,696 $176,000
Q3 2019 Oct 10, 2019	BUY	$12.27 - $15.79 $77,497 - $99,729	6,316 Added 64.39%	16,125 $214,000
Q2 2019 Aug 12, 2019	BUY	$13.37 - $18.85 $131,146 - $184,899	9,809 New	9,809 $138,000
Q4 2018 Feb 13, 2019	SELL	$18.97 - $31.47 $72,522 - $120,309	-3,823 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$18.25 - $23.0 $69,769 - $87,929	3,823 New	3,823 $88,000
Q1 2018 May 14, 2018	SELL	$14.05 - $20.2 $15,806 - $22,725	-1,125 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$12.85 - $18.1 $14,456 - $20,362	1,125	1,125 $17,000

Others Institutions Holding VNDA

# of Institutions

161

Shares Held

45.2M

Call Options Held

165K

Put Options Held

33.6K

Black Rock Inc. New York, NY

8.14M
Shares

$35.5 Million
0.0% of portfolio
Jim Simons Renaissance Technologies LLC | New York, Ny

4.01M
Shares

$17.5 Million
0.03% of portfolio
Vanguard Group Inc Valley Forge, PA

3.63M
Shares

$15.8 Million
0.0% of portfolio
Tang Capital Management LLC San Diego, CA

2.35M
Shares

$10.3 Million
0.94% of portfolio
Dimensional Fund Advisors LP Austin, TX

2.26M
Shares

$9.86 Million
0.0% of portfolio

View Full List

About Vanda Pharmaceuticals Inc.

Ticker VNDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,561,500
Market Cap $247M
Description
Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under developme...

More about VNDA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pacer Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Pacer Advisors, Inc. with notifications on news.

Account